Intellia Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$13.26

+0.45 (+3.51%)

As of Mar 25, 10:01 PM ET ·

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 15 50%

Hold 13 43%

Sell 2 7%

Price Target

Analyst Price Target +145.2% upside

Low Target $20.88

Average Target $32.51

High Target $45.64

Current Price $13.26

Current
$13.26

Target
$32.51

$20.88 $32.51 avg $45.64

Scenario Analysis

Bear Case

$20.88

57.5%

Low target

Base Case

$32.51

+145.2%

Avg target

Bull Case

$45.64

+244.2%

High target

Risk/Reward

4.2x

Highly favorable

Price in Context

52-Week High

$28.25

-53.1% from high

52-Week Low

$5.90

+124.7% from low

Target vs 52W High

$32.51

+15.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%